wegovy novo nordisk - Search News

News

Novo Nordisk, warning Doustdar

Reuters on MSN · 11h

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the obesity drug market.

Benzinga · 14h

Novo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting?

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

The Wall Street Journal on MSN · 15h

Novo Nordisk Shares Plummet as Wegovy Knockoffs Weigh on Sales

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

Novo Nordisk, Obesity Bubble

CBS News on MSN · 10h

Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs.

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.

Barron's on MSN · 10h

The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%.

The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and Ozempic in the U.S. market.

7hon MSN

Ozempic maker Novo Nordisk on track for its worst day since Black Monday

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

8h

Stock Movers: Novo Nordisk, Palo Alto, Union Pacific

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

4h

Novo Nordisk stock crashes after company cuts sales, profit outlook on weight-loss drug competition

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Jefferson Public Radio1h

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

1don MSN

Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban

A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...

Novo Nordisk's Wegovy: Battling Market Challenges Amid Rising Prescriptions

The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...

2don MSN

The Patients Forced to Switch From Zepbound to Wegovy

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

4d

Judge Rules Mylan Did Not Infringe Novo Nordisk Patent In Wegovy Generic Case

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results